Table 1

Characteristics of operable patients with early-stage NSCLC, before and after applying propensity score overlap weighting

CrudeWeighted*
Variable FEV1 <82%pred (n=234) FEV1 ≥82%pred (n=541) Standardised mean difference FEV1 <82%pred FEV1 ≥82%pred Standardised mean difference
Male, n (%)172 (73.5)288 (53.2)0.4367.167.1<0.001
Age, mean±SD, (years)59±958±90.1458±958±9<0.001
BMI, kg/m2, mean±SD23.7±3.123.6±2.80.0423.7±3.123.7±2.9<0.001
Ever smoked, n (%)126 (53.8)192 (35.5)0.3847.847.8<0.001
MET, mean±SD6.3±1.36.6±1.30.236.5±1.46.5±1.3
Medical history, n (%)
Hypertension51 (21.8)114 (21.1)0.0222.222.2<0.001
Dyslipidaemia30 (12.8)45 (8.3)0.1511.311.3<0.001
T2DM23 (9.8)44 (8.1)0.0610.010.0<0.001
CAD43 (18.4)106 (19.6)0.0319.019.0<0.001
Cerebrovascular disease5 (2.1)12 (2.2)0.011.61.6<0.001
Chronic bronchitis13 (5.6)29 (5.4)0.015.55.5<0.001
Histology, n (%)0.45<0.001
Adenomatous140 (59.8)431 (79.7)67.967.9
Squamous80 (34.2)86 (15.9)26.526.5
Others14 (6.0)24 (4.4)5.75.7
Type of lung resections, n (%)0.26<0.001
Pneumonectomy14 (6.0)11 (2.0)4.04.0
Lobectomy210 (89.7)498 (92.1)91.691.6
Segmentectomy5 (2.1)10 (1.8)2.12.1
Wedge resection1 (0.4)4 (0.7)0.50.5
No resection†2 (0.9)2 (0.4)0.70.7
Two lung lobes2 (0.9)16 (3.0)1.11.1
Clinical stage, n (%)0.21<0.001
06 (2.6)13 (2.4)2.62.6
I136 (58.1)364 (67.3)62.562.5
II34 (14.5)71 (13.1)13.613.6
IIIA58 (24.8)93 (17.2)21.321.3
  • *After applying overlap weighting, individual data points no longer corresponds to a single entity. Consequently, raw counts for categorical variables are not reported; instead, the percentages are presented.

  • †Explorative thoracotomy without lung resection.

  • BMI, body mass index; CAD, coronary artery disease; FEV1, forced expiratory volume in 1 s; MET, metabolic equivalent; NSCLC, non-small cell lung cancer; T2DM, type 2 diabetes mellitus.